Document is current
Any future updates will be listed below
-
Authors
Hosogane, Tsuyoshi https://orcid.org/0000-0002-3681-6840
Santana, Leonor Schubert
Eling, Nils https://orcid.org/0000-0002-4711-1176
Moch, Holger https://orcid.org/0000-0002-7986-2839
Bodenmiller, Bernd https://orcid.org/0000-0002-6325-7861
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_205007)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (316030_213512)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (UC4 DK108132)
Cancer Research UK (IMAXT Grand Challenge)
EC | Horizon 2020 Framework Programme (866074)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 12 November 2025
First Online: 27 November 2025
Competing interests
: B.B. is a founder and shareholder of Navignostics, a precision oncology spin-off from the University of Zurich, based on multiplexed imaging. All other authors declare no competing interests.
